Medindia

X

Stereotactic Ablative Radiotherapy Effective Treatment For Stage I NSCLC: Quality Of Life Study

by Rukmani Krishna on  June 18, 2012 at 10:13 PM Cancer News   - G J E 4
Many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life, until recently. Stereotactic ablative radiotherapy (SABR) has however become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.
 Stereotactic Ablative Radiotherapy Effective Treatment For Stage I NSCLC: Quality Of Life Study
Stereotactic Ablative Radiotherapy Effective Treatment For Stage I NSCLC: Quality Of Life Study
Advertisement

Researchers wanted to know if this treatment maintained the same health-related qualify of life levels as patients receiving surgery. The researchers received questionnaires from 382 patients treated with SABR from 68 centers in The Netherlands. The questionnaire asked patients to rate things like physical function, appetite loss, pain and emotional function.

Advertisement
The study, presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that the health-related quality of life in these patients does not seem to be negatively affected.

The authors conclude that in contrast to patients who underwent surgery, measures of qualify of life scores including a range of functional and symptom outcomes did not deteriorate in the first two years after SABR.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All